Trial Profile
A pivotal study of Varlitnib (ASLAN001) for biliary tract cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Varlitinib (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 31 Jan 2017 New trial record